FI944546A - Enantiomeerinen 1-fenyyli-2-(2pyridinyyli)etyyliamiini neurodegeneratiivisten häiriöiden hoitoon - Google Patents

Enantiomeerinen 1-fenyyli-2-(2pyridinyyli)etyyliamiini neurodegeneratiivisten häiriöiden hoitoon Download PDF

Info

Publication number
FI944546A
FI944546A FI944546A FI944546A FI944546A FI 944546 A FI944546 A FI 944546A FI 944546 A FI944546 A FI 944546A FI 944546 A FI944546 A FI 944546A FI 944546 A FI944546 A FI 944546A
Authority
FI
Finland
Prior art keywords
phenyl
treatment
neurodegenerative disorders
enantiomeric
ethylamine
Prior art date
Application number
FI944546A
Other languages
English (en)
Swedish (sv)
Other versions
FI944546A0 (fi
FI105025B (fi
Inventor
Ronald Conrad Griffith
Robert John Murray
Michael Balestra
Original Assignee
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929207339A external-priority patent/GB9207339D0/en
Priority claimed from GB929208290A external-priority patent/GB9208290D0/en
Application filed by Fisons Corp filed Critical Fisons Corp
Publication of FI944546A publication Critical patent/FI944546A/fi
Publication of FI944546A0 publication Critical patent/FI944546A0/fi
Application granted granted Critical
Publication of FI105025B publication Critical patent/FI105025B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
FI944546A 1992-04-03 1994-09-30 Menetelmä valmistaa (S)-alfa-fenyyli-2-pyridiinietaaniamiinia FI105025B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB929207339A GB9207339D0 (en) 1992-04-03 1992-04-03 Pharmaceutical compound
GB9207339 1992-04-03
GB929208290A GB9208290D0 (en) 1992-04-15 1992-04-15 Pharmaceutical compound having neuroprotective properties
GB9208290 1992-04-15
GB9300689 1993-04-01
PCT/GB1993/000689 WO1993020052A1 (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders

Publications (3)

Publication Number Publication Date
FI944546A true FI944546A (fi) 1994-09-30
FI944546A0 FI944546A0 (fi) 1994-09-30
FI105025B FI105025B (fi) 2000-05-31

Family

ID=26300643

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944546A FI105025B (fi) 1992-04-03 1994-09-30 Menetelmä valmistaa (S)-alfa-fenyyli-2-pyridiinietaaniamiinia

Country Status (29)

Country Link
EP (1) EP0633879B1 (fi)
JP (2) JP3120810B2 (fi)
KR (1) KR100259567B1 (fi)
CN (1) CN1044367C (fi)
AT (1) ATE163925T1 (fi)
AU (2) AU3897693A (fi)
CA (1) CA2133427C (fi)
CZ (1) CZ288519B6 (fi)
DE (1) DE69317411T2 (fi)
DK (1) DK0633879T3 (fi)
DZ (1) DZ1677A1 (fi)
ES (1) ES2115055T3 (fi)
FI (1) FI105025B (fi)
HK (1) HK1009331A1 (fi)
HU (1) HU211529A9 (fi)
IL (1) IL105276A (fi)
MA (1) MA22866A1 (fi)
MX (1) MX9301935A (fi)
MY (1) MY110149A (fi)
NO (1) NO302170B1 (fi)
NZ (1) NZ251384A (fi)
PL (1) PL180014B1 (fi)
RU (1) RU2128650C1 (fi)
SG (1) SG47948A1 (fi)
SK (1) SK281258B6 (fi)
TW (1) TW282455B (fi)
UA (1) UA29437C2 (fi)
WO (1) WO1993020052A1 (fi)
ZA (1) ZA932415B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320273D0 (en) * 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
SG52662A1 (en) * 1988-08-12 1998-09-28 Astra Ab Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties
ZA942140B (en) * 1993-04-01 1994-10-03 Fisons Corp Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
SE9901077D0 (sv) * 1999-03-23 1999-03-23 Astra Ab Novel use
SE9901237D0 (sv) * 1999-04-06 1999-04-06 Astra Ab Novel use
SE9901340D0 (sv) 1999-04-15 1999-04-15 Astra Pharma Prod Novel process
WO2007017652A2 (en) * 2005-08-10 2007-02-15 Astrazeneca Ab Arylakylamines for the treatment of cancer
NZ593282A (en) * 2008-12-24 2013-06-28 Astrazeneca Ab Ethanamine compounds and their use for treating depression
JP2015501652A (ja) 2011-12-14 2015-01-19 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ Ｇａｂｒ−ａ２診断
JP6479834B2 (ja) * 2013-11-05 2019-03-06 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ Ｎｍｄａアンタゴニストプロドラッグ
MX2022016183A (es) * 2020-06-23 2023-02-13 Biohaven Therapeutics Ltd Formulaciones topicas de (1s)-1-fenil-2-piridin-2-iletanamina.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG52662A1 (en) * 1988-08-12 1998-09-28 Astra Ab Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties

Also Published As

Publication number Publication date
JP3120810B2 (ja) 2000-12-25
AU705419B2 (en) 1999-05-20
UA29437C2 (uk) 2000-11-15
AU3897693A (en) 1993-11-08
NO943645D0 (no) 1994-09-30
ES2115055T3 (es) 1998-06-16
IL105276A (en) 1997-06-10
IL105276A0 (en) 1993-08-18
NZ251384A (en) 1996-10-28
CN1044367C (zh) 1999-07-28
JPH07505385A (ja) 1995-06-15
ZA932415B (en) 1993-10-22
EP0633879A1 (en) 1995-01-18
KR100259567B1 (ko) 2000-07-01
DE69317411T2 (de) 1998-07-30
WO1993020052A1 (en) 1993-10-14
HU211529A9 (en) 1995-11-28
SG47948A1 (en) 1998-04-17
EP0633879B1 (en) 1998-03-11
CN1081669A (zh) 1994-02-09
MX9301935A (es) 1994-08-31
SK117794A3 (en) 1995-05-10
RU2128650C1 (ru) 1999-04-10
RU94042465A (ru) 1996-07-20
CZ240994A3 (en) 1995-12-13
CZ288519B6 (cs) 2001-07-11
DZ1677A1 (fr) 2002-02-17
ATE163925T1 (de) 1998-03-15
AU7545696A (en) 1997-02-13
FI944546A0 (fi) 1994-09-30
HK1009331A1 (en) 1999-05-28
CA2133427C (en) 2003-06-10
TW282455B (fi) 1996-08-01
DE69317411D1 (de) 1998-04-16
CA2133427A1 (en) 1993-10-14
DK0633879T3 (da) 1998-09-28
FI105025B (fi) 2000-05-31
MA22866A1 (fr) 1993-12-31
MY110149A (en) 1998-02-28
NO302170B1 (no) 1998-02-02
PL180014B1 (pl) 2000-11-30
NO943645L (no) 1994-11-16
SK281258B6 (sk) 2001-01-18
JP2000319259A (ja) 2000-11-21

Similar Documents

Publication Publication Date Title
ITMI940326A0 (it) Derivati del 3,8-diazabiciclo[3.2.1.]lottano ad attivita' analgesica
CA2180535A1 (en) A method for treatment of psoriasis, by omeprazole or related compounds
CA2185512A1 (en) Treatment of Tinnitus Using Neuroprotective Agents
BR9609093A (pt) Uso de bis-1,2,4-triazóis para produção de um medicamento para tratamento de cãncer
FI944546A (fi) Enantiomeerinen 1-fenyyli-2-(2pyridinyyli)etyyliamiini neurodegeneratiivisten häiriöiden hoitoon
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
NO972449D0 (no) Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on 1,1 dioksidderivater og preparater og fremgangsmåte for anvendelse derav
MA24130A1 (fr) PROCEDE DE PREPARATION D'ENANTIOMERES PURS D'ACIDES CYCLO-ALCANO-INDOLAZAINDOL ET PYRIMIDO-(1,2a) INDOL - CARBOCYCLIQUES ET LEURS DERIVES
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
NO924290L (no) Azabenzimidazoler for behandling av astma, artritt og lignende lidelser
AU8715491A (en) Melatonin derivative having therapeutic activity in dermatology
AU647608B2 (en) Isoxazolylimidazole derivatives, process for their production and their use in pharmaceutical agents
IT1276321B1 (it) Derivati del carbossimetilidenecicloptimmidazolo procedimento di fabbricazione dei derivati e agenti terapeutici che contengono
IT1283265B1 (it) Procedimento ricombinante per la produzione in pseudomonas putida del citocromo c551 di pseudomonas aeruginosa.
RU95122486A (ru) Средство для лечения тикозных гиперкинезов
ES1024890Y (es) Plantilla terapeutica perfeccionada.
IT1263076B (it) Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.
ES1021777Y (es) Maquina atomizadora perfeccionada.
ES1017587Y (es) Hito perfeccionado.
ES1021588Y (es) Portarrollos perfeccionados.
ES1020598Y (es) Porta-rollos perfeccionado.
ITMI931684A1 (it) Procedimento per la preparazione di derivati del 3, 4-diidrocarbostirile
ITMI921770A1 (it) Composizioni farmaceutiche atte al trattamento dei disturbi della memoria.
ES1021895Y (es) Figura de centauro articulada, perfeccionada.
ES1019711Y (es) hito de arista perfeccionado.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ASTRA AB

MA Patent expired